Clinical trials
Peritonitis clinical trials
Below are recruiting peritonitis clinical trials, each written for real people, not researchers. We’re tracking 255 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05092373RecruitingPhase 1
Tumor treating device plus targeted or immune drugs for advanced cancers
This Phase 1 study tests whether a tumor treating fields device works better when added to standard cancer drugs. It may help people with advanced solid tumors in the chest or belly, especially when standard treatment didn’t work or can’t be tolerated.
Houston, TexasAges 18 years+ - NCT04575935RecruitingPhase 3
Minimally invasive surgery after chemotherapy for advanced ovarian cancer
This trial studies whether doing surgery using smaller incisions after chemotherapy works as well as a more traditional approach for certain people with stage IIIC–IV ovarian, fallopian tube, or primary peritoneal cancer. It may help reduce surgical trauma while aiming for effective tumor removal.
Miami, FloridaAges 18 years+ - NCT06639074RecruitingPhase 2
Folate receptor dendritic cell vaccine for ovarian cancer
This trial tests a personalized vaccine made from your own immune cells, designed to target a protein called folate receptor alpha found on many ovarian cancer cells. It is for people who have finished initial chemotherapy and have no signs of cancer remaining, to try to prevent it from coming back.
Scottsdale, ArizonaAges 18 years+ - NCT04919629RecruitingPhase 2
Tested treatments for recurrent ovarian cancer with fluid buildup
This Phase 2 study tests whether adding two medicines—APL-2 plus pembrolizumab or pembrolizumab plus bevacizumab—works better than bevacizumab alone for recurrent ovarian, fallopian tube, or primary peritoneal cancer. It also focuses on people who have symptoms from cancer-related fluid (ascites or pleural effusion).
Buffalo, New YorkAges 18 years+ - NCT06855706Recruiting
Personalized physical activity program for ovarian and endometrial cancers
This study tests whether a personalized, automated physical activity program (using a Fitbit and continuous glucose monitor) can improve immune function and health outcomes in people with advanced ovarian, primary peritoneal, fallopian tube, or newly diagnosed endometrial cancer. You'll wear an activity tracker, answer questionnaires, and provide blood and stool samples at Roswell Park.
Buffalo, New YorkAges 18 years+ - NCT03932461Recruiting
Wound suction vs immediate re-operation for severe bowel infection
This trial compares two ways of treating the abdomen after emergency surgery when there is severe contamination from a bowel perforation causing widespread peritonitis. It may help find the safest approach to control infection and promote healing.
Odense, FynAges 19 years+ - NCT07724327Enrolling by invitation
AI assistant for peritoneal dialysis decisions
This study tests whether a special AI tool can help doctors make better decisions about peritoneal dialysis (a type of kidney treatment). You will use the AI to answer clinical scenarios and your answers will be compared to others.
Guangzhou, GuangdongAges Any age - NCT06597201RecruitingPhase 4
Testing Amino Acid Dialysis Solution for Malnutrition on Peritoneal Dialysis
This trial tests a special peritoneal dialysis solution with amino acids (protein building blocks) to improve nutrition in people on CAPD who are malnourished. It might help boost your protein levels and overall health.
Hefei, AnhuiAges 18–75 - NCT07370441Enrolling by invitationPhase 4
Amino acid dialysis fluid for better nutrition
This trial tests a special dialysis fluid with amino acids (building blocks of protein) to see if it helps improve nutrition in people on peritoneal dialysis who have low protein levels. If you qualify, it may help boost your nutrition.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07282834RecruitingPhase 2
Comparing two types of heated chemo for abdominal cancer spread
This trial tests if giving heated chemotherapy as a mist (aerosol) is better than as a liquid for cancer that has spread to the lining of the abdomen. It is for people who have already had at least three months of standard chemo but still have disease and cannot have surgery right now.
Pittsburgh, PennsylvaniaAges 18–80 - NCT07001592RecruitingPhase 1
Injection of a modified virus for advanced GI and peritoneal cancers
This trial tests a modified virus injected directly into tumors to treat metastatic gastrointestinal and peritoneal cancers. It aims to see if this approach can shrink tumors or slow their growth.
Pittsburgh, PennsylvaniaAges 18–69 - NCT06483048RecruitingPhase 1
MUC1-targeted T cells for relapsed ovarian cancer
This trial tests a new treatment using your own immune cells, modified to target a protein called MUC1 on ovarian cancer cells. It is for people with ovarian cancer that has come back or is resistant to standard treatments.
Scottsdale, ArizonaAges 18 years+ - NCT05231122RecruitingPhase 2
Pembrolizumab and bevacizumab for recurrent ovarian cancer
This trial studies whether adding pembrolizumab to bevacizumab (and sometimes an anti-CD40 drug) can help control recurrent ovarian, fallopian tube, or primary peritoneal cancer. It also looks at whether the treatment can shrink tumors and keep them from growing for longer.
Buffalo, New YorkAges 18 years+ - NCT04847063RecruitingPhase 1
Test drug heating inside the abdomen for peritoneal cancer
This Phase 1 trial tests a treatment that delivers heated chemotherapy directly into the abdomen (HIPEC) for certain cancers that have spread only within the abdominal lining. It aims to see how safely and effectively this approach works, especially when doctors can remove as much tumor as possible.
Bethesda, MarylandAges 18–120 - NCT03968406RecruitingPhase 1
Talazoparib plus radiation for recurrent gynecologic cancers
This Phase 1 study tests whether the cancer drug talazoparib, combined with radiation, can better control recurrent gynecologic cancers in the pelvis/abdomen. It focuses on patients whose cancer has come back locally enough that radiation can be given, while other disease is not rapidly worsening.
Baltimore, MarylandAges 18 years+ - NCT04714957Recruiting
Personalized study for cancer spread in the belly lining
This trial studies people whose cancer has spread to the lining of the abdomen (the “belly lining”), including cancers from the digestive tract or ovaries. You may be asked to join because the study aims to learn how to better match care to different patterns of this belly lining cancer spread.
LyonAges 18 years+ - NCT05722275Recruiting
Predicting peritoneal spread in advanced stomach cancer
This trial uses CT scan images and a look inside the abdomen (laparoscopy) to predict whether advanced stomach cancer has spread to the lining of the abdomen (the peritoneum). It may help your care team better identify who already has peritoneal spread and who might not.
BeijingAges 18 years+ - NCT05971537RecruitingPhase 4
Antibiotic lock treatment for repeat peritonitis in catheter patients
This trial studies using an “antibiotic lock” inside a Tenckhoff catheter to prevent relapsing or repeat peritonitis in people on peritoneal dialysis. It may help stop infections that come back soon after antibiotics, especially when the same germ is causing them.
Tai PoAges 18 years+ - NCT07539428Enrolling by invitation
Testing AI tool for peritoneal dialysis doctors and trainees
This trial tests a specialized artificial intelligence tool designed to help doctors and residents manage peritoneal dialysis (a kidney treatment where fluid is exchanged through the abdomen). Researchers want to see if the AI tool can help healthcare providers improve their decision-making and care for patients on this treatment.
Guangzhou, GuangdongAges Any age - NCT07475286RecruitingPhase 2
Chemo for stomach cancer that has spread to the abdomen lining
This trial tests giving chemotherapy into the abdomen during surgery for stomach or gastroesophageal junction cancer that has spread to the lining of the abdomen (peritoneal carcinomatosis). It aims to see if this approach can help control the disease better.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT07077538Recruiting
Amino acid dialysis fluid for diabetic patients on PD
This study tests a special dialysis fluid made with amino acids (protein building blocks) instead of the usual sugar-based fluid. It may help control blood sugar and improve nutrition in people with diabetes on peritoneal dialysis.
Gaozhou, GuangdongAges 18–75 - NCT06929013Recruiting
Blood marker study for colorectal cancer spread to belly
This study looks at how certain blood markers (nucleosome and CTCF) clear from the body in people with colorectal cancer that has spread to the lining of the belly. It also includes people with other conditions to compare. The goal is to learn more about these markers to help guide treatment.
Pierre-BéniteAges 18 years+ - NCT06842927Enrolling by invitation
A tool to measure how well peritoneal dialysis works
This study is testing a new computer tool that helps doctors see how well peritoneal dialysis (a type of kidney treatment done at home) removes waste from your body. It may help make your dialysis more effective.
TuenmenAges 18 years+ - NCT06580314RecruitingPhase 3
Olaparib with or without bevacizumab for ovarian cancer
This trial tests whether taking the drug olaparib for one or two years, alone or with another drug called bevacizumab, can help keep ovarian cancer from coming back after initial chemotherapy and surgery. It is for people with certain genetic markers in their tumor.
Birmingham, AlabamaAges 18 years+
Hear when a new Peritonitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for peritonitis?
- Yes. Clin2 currently lists 255 recruiting peritonitis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a peritonitis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a peritonitis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.